ID
13020
Description
Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00083694
Link
https://clinicaltrials.gov/show/NCT00083694
Keywords
Versions (1)
- 1/12/16 1/12/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 12, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Leukemia NCT00083694
Eligibility Leukemia NCT00083694
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnant or lactating women
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
chemotherapy or radiation
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C1522449
Description
seizures, neurotoxicity, or active cns disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0036572
- UMLS CUI [2]
- C0235032
- UMLS CUI [3]
- C0007682
Description
infections
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Similar models
Eligibility Leukemia NCT00083694
- StudyEvent: Eligibility
C1522449 (UMLS CUI [2])
C0235032 (UMLS CUI [2])
C0007682 (UMLS CUI [3])